Provided by Tiger Trade Technology Pte. Ltd.

HUA MEDICINE-B

2.860
+0.0200.70%
Volume:3.71M
Turnover:10.74M
Market Cap:3.02B
PE:-11.22
High:2.980
Open:2.790
Low:2.770
Close:2.840
52wk High:4.950
52wk Low:1.410
Shares:1.06B
HK Float Shares:1.06B
Volume Ratio:1.04
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.255
ROE:209.75%
ROA:-9.41%
PB:2.53
PE(LYR):-11.22
PS:7.24

Loading ...

Hua Medicine (02552) Releases Monthly Return on Movements in Securities for January 2026

Bulletin Express
·
Feb 05

Hua Medicine (Shanghai) Ltd.'s (HKG:2552) stock price dropped 13% last week; individual investors would not be happy

Simply Wall St.
·
Feb 03

HUA MEDICINE-B (02552) Rises Over 3% as Second-Gen GKA Completes First Dosing in U.S. MAD Ib Trial, Eyes Future Partnerships

Stock News
·
Dec 10, 2025

HUA MEDICINE-B (02552): First Patient Successfully Dosed in U.S. MAD Ib Trial for Second-Generation GKA HMS1005

Stock News
·
Dec 09, 2025

Hua Medicine Doses First Patient in US Phase Ib Trial of HMS1005 for Type 2 Diabetes

Reuters
·
Dec 09, 2025

Hua Medicine (02552) Releases November 2025 Monthly Return, No Change in Issued Shares

Bulletin Express
·
Dec 04, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

HK Stock Movement | HUA MEDICINE-B (02552) Rises Over 4% in Late Trading as Second-Generation GKA Submits Clinical Application to FDA, Leading Industry R&D

Stock News
·
Dec 01, 2025

HUA MEDICINE-B (02552) Grants 20 Million Share Options in Total

Stock News
·
Dec 01, 2025

Hua Medicine (2552) Announces Grant of 20,000,000 Share Options

Bulletin Express
·
Dec 01, 2025

Hua Medicine (2552) Announces Change in Remuneration Committee

Bulletin Express
·
Nov 27, 2025

Hua Medicine Files Directors List to HKEX

Reuters
·
Nov 27, 2025

HUA MEDICINE-B (02552): Zhang Yaoliang Appointed as Member of Remuneration Committee

Stock News
·
Nov 27, 2025

Hua Medicine Appoints Andy Cheung to Remuneration Committee

Reuters
·
Nov 27, 2025

Guosheng Securities Initiates Coverage on HUA MEDICINE-B (02552) with "Buy" Rating, Citing Leadership in Global GKA Diabetes Treatment

Stock News
·
Nov 24, 2025

Hua Medicine (02552) Releases Monthly Return as of 31 October 2025

Bulletin Express
·
Nov 06, 2025

Hong Kong Stock Movement | HUA MEDICINE-B (02552) Surges Over 14% as Commercial Transformation Shows Significant Results, Huatangning Sales Double in First Half

Stock News
·
Sep 04, 2025

Stock Track | HUA MEDICINE-B Soars 5.88% Following Impressive Interim Results and First-Time Profitability

Stock Track
·
Sep 02, 2025

Stock Track | HUA MEDICINE-B Soars 5.88% on First-Half Profitability and Successful Commercialization

Stock Track
·
Sep 02, 2025

Hong Kong Stock Movement | HUA MEDICINE-B (02552) Surges Nearly 6% Again as Company Achieves First-Half Profitability with Remarkable Autonomous Commercialization Results

Stock News
·
Sep 02, 2025